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Pore-forming toxins (PFTs) secreted by pathogenic
bacteriaare themostcommonbacterialprotein toxins
andare important virulence factors for infection. PFTs
punch holes in host cell plasma membranes, and
althoughcells cancounteract the resultingmembrane
damage, the underlying mechanisms at play remain
unclear. Using Caenorhabditis elegans as a model,
we demonstrate in vivo and in an intact epithelium
that intestinal cells respond to PFTs by increasing
levels of endocytosis, dependent upon RAB-5 and
RAB-11, which are master regulators of endocytic
and exocytic events. Furthermore, we find that RAB-
5 and RAB-11 are required for protection against
PFT and to restore integrity to the plasmamembrane.
One physical mechanism involved is the RAB-11-
dependent expulsion of microvilli from the apical
side of the intestinal epithelial cells. Specific vesicle-
trafficking pathways thus protect cells against an
attack by PFTs on plasma membrane integrity, via
altered plasma membrane dynamics.
INTRODUCTION
Pore-forming toxins (PFTs) are virulent bacterial proteins that
perforate host cell plasma membranes to disable cellular
viability, alter cytokine responses, and provide the pathogen
nutrients (Aroian and van der Goot, 2007; Bischofberger et al.,
2009). Many well-known pathogenic bacteria such as Staphylo-
coccus aureus, group A and B streptococci, Vibrio cholerae, and
Clostridium septicum employ PFTs (Aroian and van der Goot,
2007; Labandeira-Rey et al., 2007; Olivier et al., 2007). With
25%–30% of all known virulent proteins, PFTs form the largest
class of bacterial toxins (Alouf, 2003; Gonzalez et al., 2008).
It was recently shown that the large-pore PFT SLO, the small-
pore PFT a toxin, andmedium-sized perforin pores trigger endo-Cell Hostcytic and/or exocytic events, which correlate with plasma
membrane resealing (Husmann et al., 2009; Idone et al.,
2008a, 2008b; Tam et al., 2010; Thiery et al., 2010). Correlation
between these processes and cellular survival were not tested
for SLO, but the data suggest that inhibition of endocytosis
causes decreased survival when cells are exposed to a toxin
(Husmann et al., 2009), and perforin induced a shift from necrotic
to apoptotic cell death (Thiery et al., 2010). These in vitro studies
show that vesicle trafficking is involved in restoring plasma
membrane integrity after an attack by PFT. However, conclusive
demonstration that these events contribute to cellular survival
after PFT attack and especially of their relevance toward produc-
tive responses in an intact tissue in vivo are currently lacking.
The roundwormCaenorhabditis elegans is extensively used as
a model for mammalian pathogenesis and innate immune
responses (Alegado et al., 2003; Schulenburg et al., 2004; Sifri
et al., 2005). It has also been developed as a system to study
cellular defenses against PFTs in vivo and has proven instru-
mental in the identification of specific molecular PFT-defense
pathways (Bellier et al., 2009; Bischof et al., 2008; Chen et al.,
2010; Huffman et al., 2004). Where tested, theseC. elegans find-
ings always extended to mammalian systems (Bischof et al.,
2008; Huffman et al., 2004). C. elegans has furthermore been
developed into a relevantmodel to study vesicle trafficking (Grant
and Donaldson, 2009). Using this system, we address a number
of the uncertainties surrounding the physical mechanisms em-
ployedbycells to restore integrity to theirmembranes andsurvive
an attack by PFTs. We show a clear correlation between vesicle
trafficking, plasma membrane repair, and survival in response to
a bacterial PFT in vivo in an intact tissue context. We furthermore
demonstrate a requirement of RAB-5 and RAB-11, master regu-
lators of endocytic and exocytic events, in these processes and
involvement of microvilli expulsion from the cell surface.
RESULTS
PFTs Induce Intracellular Relocalization
of Plasma Membrane Markers
To study the effects of PFTs on the plasmamembrane in vivo, we
used a C. elegans strain expressing PGP-1::GFP, a labeled ATP& Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc. 147
Figure 1. PFTs Induce Uptake of Apical
Plasma Membrane Markers
(A) Differential interference contrast (DIC) image of
anterior half of C. elegans, with intestine false
colored in blue and pharynx in green; arrowheads
indicate the transition from pharynx to intestine,
and the arrow indicates the posterior bulb of the
pharynx (left). The fluorescence image (middle)
and overlay over DIC image (right) show that
PGP-1::GFP marks the apical plasma membrane
of C. elegans intestinal cells. The scale bar repre-
sents 50 mm.
(B) Confocal images of PGP-1::GFP after 0 (left) or
2 (middle) hr exposure to E. coli-expressed Cry5B.
The indicated area in the middle panel was magni-
fied 33 (right), with arrows indicating intracellular
PGP-1::GFP-positive vesicular structures. Scale
bars represent 25 mm (left; same for middle) and
10 mm (right).
(C) Confocal images showing intracellular PGP-
1::GFP-positive vesicular structures after 5 min
exposure to E. coli-expressed Cry5B, which are
absent from untreated animals. Panels and scales
are as in (B).
(D) Deconvolved images showing that V. cholerae
expressing VCC induces PGP-1::GFP relocaliza-
tion to intracellular vesicular structures after 2 hr
exposure (middle and right), whereas V. cholera
lacking VCC does not (left). Occasionally, vesicles
are visible in control images; thesewere confirmed
to be autofluorescent gut granules (see the Exper-
imental Procedures). Scale bars represent 25 mm
(left; same for middle) and 10 mm (right).
See also Figure S1 and Table S2.
Cell Host & Microbe
RAB-5 and RAB-11 in Removal of Pore-Forming Toxinbinding-cassette (ABC) transporter that, in fourth larval stage
(L4) animals, localizes strictly to the apical plasma membrane
of the intestinal cells (Sato et al., 2007) (Figure 1A). When L4
animals are exposed on agar plates to Cry5B PFT transgenically
expressed by Escherichia coli (the normal laboratory food source
for C. elegans), a striking relocalization of the GFP marker is
observed, from the apical plasma membrane to intracellular
vesicular structures (Figure 1B). Although most dramatic after
at least 2 hr, this phenotype is observed as early as 5 min after
exposure to PFT (Figure 1C). After 2 hr on E. coli-expressed
Cry5B, 96.9% of the animals show the marker on intracellular
vesicular structures, versus 0.0% in control-treated animals
(p < 0.0001) (Table S1 available online).
For confirmation that the observed phenotype was not an arti-
fact of PGP-1::GFP, another apical plasma-membrane marker148 Cell Host & Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc.was tested, OPT-2::GFP, a labeled
peptide transporter (Nehrke, 2003).
OPT-2::GFP similarly relocalizes to intra-
cellular vesicular structures after treat-
ment with Cry5B PFT (Figure S1A).
The results extend to other small-pore
PFTs, as PGP-1::GFP also relocalizes to
intracellular vesicles after exposure to
Cry21A, another Bt crystal PFT that intox-
icates nematodes (Wei et al., 2003)
(92.4% of animals for Cry21A versus0.0% for controls, p < 0.0001; Table S1 and Figure S1B), or to
a V. cholerae strain expressing VCC (48.4% with VCC versus
1.9% without VCC, p < 0.05; Table S1 and Figure 1D). To
examine the specificity of this response to PFTs, we exposed
PGP-1::GFP animals for 2 hr to various other stressors, namely
the pathogenic bacterium Pseudomonas aeruginosa (strain
PA14, which kills C. elegans without apparently relying on
a PFT [Bischof et al., 2008]), a high dose of the heavy metal
copper (10 mM CuSO4 [Bischof et al., 2008]), hyper osmotic
stress (400 mM NaCl [Lamitina et al., 2006]), and 35C heat
stress. None of these treatments induce PGP-1::GFP relocaliza-
tion (Table S1 and Figure S1C), indicating that the observed
response is not caused by cellular stress per se.
Relocalization of apical plasmamembranemarkers to intracel-
lular punctate structures in C. elegans thus represents
Figure 2. PFTs Induce Plasma Membrane
Uptake intoEarly Endosomesand Increased
Rates of Endocytosis
(A) PGP-1::GFP-positive vesicles induced by
2 hr exposure to E. coli-expressed Cry5B PFT
and vesicles positive for mCherry::RAB-5 overlap
(indicated by arrows). Due to intensity differences,
overlapping signals do not always appear yellow
in merged image. Autofluorescence is shown
in blue in the merged image. The scale bar
represents 10 mm.
(B) Two hour exposure to V. cholerae VCC induces
PGP-1::GFP-positive vesicles that show similar
overlap with RAB-5::mCherry. Scale is as in (A).
(C) After 2 hr exposure to TRITC-labeled BSA in
absence of toxin, the dye is confined to the
intestinal lumen. After simultaneous exposure to
1 mg/ml purified Cry5B PFT, TRITC-BSA is abun-
dantly found inside intestinal cells. The scale bar
represents 25 mm.
(D) Quantification of TRITC-BSA fluorescence, in
the absence or presence of 1 or 15 mg/ml purified
Cry5B PFT, demonstrates that PFT attack leads
to increased signal intensity, consistent with
increased endocytosis. Means of three experi-
ments are shown. Error bars are standard error
of the mean. Statistics indicated here and else-
where are as follows: ns, not significant; *** p <
0.001; * p < 0.05.
See also Figure S2 and Tables S1 and S2.
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PFTs.
PFTs Cause Increased Rates of Endocytosis
Most endocytosed cargo is thought to travel through early endo-
somes (Grant and Donaldson, 2009), which are labeled by
mCherry::RAB-5 (Shi et al., 2009). When worms expressing
both PGP-1::GFP and mCherry::RAB-5 are exposed to E. coli-
expressed Cry5B, overlap is seen between PGP-1::GFP-labeled
and RAB-5::mCherry-labeled vesicles (Figure 2A). The same
is seen when these animals are exposed to V. cholerae that
express VCC (Figure 2B). The colocalization of PGP-1::GFP
and RAB-5::mCherry indicates that relocalization of PGP-
1::GFP to punctate intracellular structures upon PFT attack
marks an endocytic event.
These data suggest that levels of endocytosis are increased in
the presence of Cry5B PFT. When fed to C. elegans, tetrame-
thylrhodamine isothiocyanate-labeled bovine serum albumin
(TRITC-BSA) eventually localizes to autofluorescent gut granules
in the intestinal cells, thought to be lysosomes, and can therefore
be used to visualize fluid phase endocytosis (Hermann et al.,
2005). We imaged animals after 2 hr exposure to 0, 1, or
15 mg/ml purified Cry5B in the presence of TRITC-BSA and
quantified fluorescence intensity in the eight anterior-most intes-
tinal cells to measure the amount of endocytosis that had
occurred. Images from the experiment (Figure 2C) as well asCell Hostthe quantification (Figure 2D and Table S1) show significantly
increased TRITC-BSA fluorescence in the presence of Cry5B
PFT. BSA has a diameter of 6.26 nm (Wu and Prausnitz, 1999)
and is unlikely to passively diffuse into the cells through the
1- to 2-nm-sized Cry5B pores (Parker and Feil, 2005). Increased
fluorescence was not due to altered autofluorescence of the
intestine, as signals measured in the same experiments in the
UV channel (indicating autofluorescence [Clokey and Jacobson,
1986]) showed no statistical difference between Cry5B- and
control-treated animals (Figures S2A and S2B and Table S1).
Thus, PFTs trigger endocytosis in C. elegans in vivo, consistent
with observations in PFT-treated mammalian cells (Husmann
et al., 2009; Idone et al., 2008b; Thiery et al., 2010).
RAB-5 and RAB-11 Are Required for Cellular
Protection against PFT
RAB small GTPases are key regulators of vesicle-trafficking
events (Grant and Donaldson, 2009), and we hypothesized that
RABs would be involved in PFT defenses. We therefore did a
provisional analysis of the involvement of various RABs (RAB-
1, -5, -6.1, -6.2, -7, -11.1, -14, -21, -28, -37, and -39 and UNC-
108) in Cry5B defense in C. elegans, using RNA interference
(RNAi) and subsequent exposure to E. coli-expressed Cry5B.
This analysis yielded RAB-5 and RAB-11 as candidates, which
led us to further investigate their roles in cellular responses to
Cry5B. RAB-5, found on PFT-induced PGP-1::GFP-containing& Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc. 149
Figure 3. RAB-5 andRAB-11 AreRequired for Defense
against Cry5B PFT
(A) rrf-3(pk1426) animals after rab-5 or rab-11.1 RNAi are
qualitatively hypersensitive to a low (10%) dose of E. coli-
expressed Cry5B PFT after 48 hr exposure. The scale bar
represents 0.5 mm.
(B) VP303 animals grown in liquid on rab-5, rab-11.1, or sek-1
RNAi bacteria show significantly decreased survival rates on
15 mg/ml purified Cry5B, whereas pgp-1 and empty vector
(L4440) controls do not.
(C) In simultaneously performed assays, the same RNAi treat-
ments did not cause significant hypersensitivity to CuSO4.
(B) and (C) show the means of at least three independent
experiments. Statistics indicate the difference between toxin
treatment and its accompanying no-toxin control for each
RNAi treatment. Error bars represent the standard error of
the mean.
See also Figure S4 and Tables S1 and S2.
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RAB-5 and RAB-11 in Removal of Pore-Forming Toxinvesicles (Figures 2A and 2B), is the C. elegans homolog of Rab5,
a master regulator of trafficking from the plasma membrane to
early endosomes (Grant and Hirsh, 1999; Grant and Donaldson,
2009). Rab11 directs vesicles from the recycling endosome to
the plasma membrane (Grant and Donaldson, 2009) and func-
tions to regulate trafficking from the trans-Golgi network to the
plasma membrane (Grant and Hirsh, 1999). The C. elegans
genome encodes two closely related Rab11 homologs, rab-
11.1 and rab-11.2, which differ mainly in the C-terminal region
(Figure S3). By quantitative real time PCR, using primers that
anneal to where rab-11.1 and rab-11.2 differ most, we found
that rab-11.1 and rab-11.2 are both expressed in C. elegans,
although rab-11.1 was expressed at higher levels than rab-
11.2. Given the 85.2% identity between rab-11.1 and rab-11.2
nucleic acid sequences, it is likely our RNAi experiments below
target both genes.
We wanted to determine whether RAB-5 and RAB-11 fulfill
a role in protection against PFT attack. Because rab-5 and rab-
11.1 are essential for development (Grant and Hirsh, 1999), no
mutants are available that lend themselves for our assays, and
we used feeding RNAi. We found that rab-5 and rab-11.1 RNAi
also inhibit normal development, so we resorted to diluting the
rab-5 and rab-11.1 double-stranded RNA (dsRNA)-expressing
bacteria with empty vector control bacteria, effectively lowering
the RNAi dose and allowing superficially normal development.150 Cell Host & Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc.The genetic background and sensitivity to RNAi of
the different C. elegans strains used in this study
varies, and for each strain we used the lowest
dilution, or highest dose, of RNAi bacteria that still
allowed normal development of the worms. The
worm strains and RNAi dilutions used are discussed
in Table S2. To confirm that diluted RNAi still caused
knockdown of gene expression, we exposed RAB-
5::GFPorRAB-11.1::GFPanimals to thehighestdilu-
tions (lowest concentrations) of, respectively, rab-5
and rab-11.1 RNAi used in this study. Under these
conditions, RNAi still results in efficient suppression
of GFP expression (Figures S4A and S4B).
Todeterminea requirementofRAB-5andRAB-11
in PFT defense, we exposed rrf-3(pk1426) RNAi-hypersensitive animals to diluted RNAi against rab-5 and
rab-11.1, followed by 48 hr exposure to E. coli-expressed Cry5B
on solid medium. Vector-RNAi control animals are only mildly
affected by a low dose of PFT, but animals grown on rab-5 or
rab-11.1 RNAi are significantly more intoxicated (Figure 3A).
VPS-45 and RABX-5 are important factors for RAB-5 function
(Gengyo-Ando et al., 2007; Sato et al., 2005).We found thatmuta-
tion of vps-45 or rabx-5, or RNAi against vps-45, caused qualita-
tive hypersensitivity to E. coli-expressed Cry5B (Figures S4C
and S4D), which further validates the role of rab-5 and of endocy-
tosis in PFT defenses.
Since Cry5B PFT attacks the C. elegans intestine (Griffitts
et al., 2001), we wanted to quantitatively determine the require-
ment of rab-5 and rab-11.1 for PFT defense in this tissue. We
therefore performed RNAi against these genes in C. elegans
strain VP303, which allows for RNAi to predominantly knock
down gene expression in the intestine (see Table S2). Animals
were grown in liquid on RNAi to the L4 larval stage, at which point
purified Cry5B PFT was added, and survival was scored 6 days
later. RNAi against rab-5, rab-11.1, and sek-1 (p38MAPKK, used
as a hypersensitive control [Huffman et al., 2004]) caused signif-
icantly lower survival on Cry5B (Figure 3B and Table S1).
RNAi against pgp-1 was used as a negative control because
activity of the clone could easily be confirmed by its ability to
suppress PGP-1::GFP expression (data not shown). pgp-1
Figure 4. RAB-5 and RAB-11 Are Required for PFT-Induced Endocy-
tosis
(A) PGP-1::GFP animals show a diminished endocytic response to E. coli-
expressed Cry5B PFT when grown on rab-5 or rab-11.1 RNAi. Images show
the anterior half of intestine. The scale bar represents 25 mm.
(B) Fractions of population showing PGP-1::GFP on endocytic vesicles
after RNAi against rab-5, rab-11.1, or sek-1 and subsequent exposure to
E. coli-expressed Cry5B. L4440 is empty vector control. Means of at least
six independent experiments are shown. Error bars represent the standard
error of the mean.
See also Tables S1 and S2.
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RAB-5 and RAB-11 in Removal of Pore-Forming ToxinRNAi causes significantly compromised survival in the absence
of toxin but does not cause hypersensitivity to Cry5B PFT (Fig-
ure 3B and Table S1), demonstrating that compromised health
per se does not lead to increased PFT sensitivity. To directly
confirm that the observed Cry5B-hypersensitivity caused by
rab-5 or rab-11.1 RNAi was not due to general poor health, we
tested survival on 2mMCuSO4 (simultaneously with the previous
experiment and in identical setup). We found that at this dose,
which causes a low fraction of lethality in C. elegans (Bischof
et al., 2008), RNAi against rab-5, rab-11.1, pgp-1, or sek-1
does not cause significant hypersensitivity (Figure 3C and Table
S1). Based on our data that (1) diluted rab-5 and rab-11.1 RNAi
permit normal development and survival in absence of toxin,
(2) decreased survival caused by pgp-1 RNAi in the absence of
PFT does not lead to increased PFT sensitivity, and (3) rab-5
and rab-11.1 RNAi animals are not hypersensitive to CuSO4,
we conclude that the PFT hypersensitivity caused by reduction
of rab-5 and rab-11 function is not due to overall compromised
health, but that there is a specific role for RAB-5- and RAB-11-
mediated vesicle-trafficking pathways in the affected tissue in
PFT defense.
RAB-5 and RAB-11 Are Required for PFT-Induced
Vesicle Formation
The formation of vesicles upon addition of PFT and the protec-
tive effect of RAB-5 and RAB-11 vesicle-trafficking pathways
suggest that the vesicles themselves are involved in RAB-5-
and RAB-11-mediated protection. This predicts the formation
of these vesicles to be dependent upon RAB-5 and/or RAB-11.
To test this, we exposed PGP-1::GFP-expressing animals to
diluted rab-5 or rab-11.1 RNAi (see Table S2) and subsequently
to Cry5B. Both RNAi treatments caused significant inhibition of
the PFT-induced endocytic response, as measured by the frac-
tion of animals showing PGP-1::GFP-containing intracellular
vesicles (Figures 4A and 4B and Table S1). Furthermore, animals
grown on rab-5 or rab-11.1 RNAi that still showed GFP relocali-
zation in response to Cry5B generally contained fewer vesicles.
Interestingly, RNAi against the p38 MAPKK sek-1 did not alter
the endocytic response (Figure 4B and Table S1). No differences
in PGP-1::GFP localization were noticed between controls and
any of the RNAi-treated animals in the absence of toxin. These
data indicate that there is a correlation between PFT protection
and vesicle formation dependent upon RAB-5 and RAB-11 and
that the p38 MAPK pathway is not likely to be upstream of this
process in this time frame. The fact that RNAi of rab-11.1, which
is involved in exocytosis, results in defects in endocytosis is likely
to be a consequence of the fact that cells maintain a balance of
endocytosis and exocytosis. Loss of exocytosis will therefore
also result in rapid loss of endocytosis as cells naturally compen-
sate to maintain homeostasis of the plasma membrane.
Vesicle-Trafficking Pathways Remove Pores
from the Plasma Membrane
Vesicle-trafficking pathways may provide protection against
PFTs by dynamically removing pores from the membrane,
perhaps by endocytosis of pore-contaminated membrane (Bis-
chofberger et al., 2009; Idone et al., 2008a, 2008b). To test
whether pores were being removed from the membrane, we
developed an in vivo assay involving the small dye propidiumCell Hostiodide (PI), commonly used to study the presence of membrane
pores in vitro (Idone et al., 2008b; Tam et al., 2010; Thiery et al.,
2010; Walev et al., 2001), inspired by a published assay for
membrane integrity in C. elegans intestinal cells (Luke et al.,
2007). PI is membrane impermeable and, when fed to live C. el-
egans, is restricted to the intestinal lumen (Figure 5A). The
molecular diameter of PI is less than 0.96 nm (Iwase et al.,
1990), whereas the predicted pore size for Cry5B is 1 to 2 nm
(Parker and Feil, 2005). When fed to worms in liquid in the pres-
ence of purified Cry5B for 2 hr, PI stains the cytosol of the intes-
tinal cells (Figure 5B). The same was observed when animals
were exposed to E. coli-expressed Cry5B on solid medium
and subsequently stained with PI (data not shown). To confirm
that PI enters the cells via diffusion through pores and not via
endocytosis like TRITC-BSA (see above), we studied uptake of
the two dyes after a short exposure to PFT. We found that after
a short (15 min) Cry5B exposure, small amounts of TRITC-BSA
had entered the intestinal cells relative to what remained in the
lumen, suggesting that BSA uptake is rate limited, consistent
with an endocytic process (Figure S5A). However, large amounts
of PI had entered the cells relative to what was still present in the
lumen (Figure S5B), consistent with passive diffusion of PI
through pores. This finding is further reinforced by experiments
below.
To determine whether cells are able to rectify membrane
permeability to PI after PFT attack, we pulsed animals for
15 min with E. coli-expressed Cry5B and allowed 30 min or
24 hr recovery prior to staining with PI. We found that 92.6% of
the animals have PI-permeable intestinal cells 30 min after the
Cry5B pulse, whereas only 18.3% had PI-permeable intestinal& Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc. 151
Figure 5. RAB-5 and RAB-11 Are Required
for Removal of PFT from the Plasma
Membrane
(A) PI is restricted to the intestinal lumen when
fed to C. elegans. PGP-1::GFP marks the apical
boundary of the intestinal cells. The scale bar
represents 25 mm.
(B) PI stains the cytosol of the intestinal cells when
animals are simultaneously exposed to purified
Cry5B PFT for 2 hr. Scale is as in (A).
(C) Fractions of population showing cytosolic PI
staining after 0.5 or 24 hr recovery after a 15 min
pulse with E. coli-expressed Cry5B. After 0.5 hr
recovery, all RNAi treatments resulted in statisti-
cally equal fractions of animals with compromised
integrity (internalized PI) of the intestinal cells. The
majority of control (L4440) animals and animals on
pgp-1RNAi have repaired their intestinal cells after
24 hr recovery. RNAi against rab-5 or rab-11.1
causes significantly impaired repair after 24 hr.
Means of at least three independent experiments
are shown. Error bars represent the standard error
of the mean.
See also Figure S5 and Tables S1 and S2.
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judged by PFT-mediated permeabilization of intestinal cells to
PI, 74.3% (92.6%–18.3%) of wild-type animals are able to elim-
inate all pores from their membrane during the 24 hr after a brief
PFT pulse. During preliminary experiments, we found interme-
diate fractions of animals showing membrane repair at time
points between 0.5 and 24 hr (data not shown). Also, animals
showing a mosaic repair pattern were occasionally found—i.e.,
some of the cells contained PI, whereas others did not (Fig-
ure S5C)—which was never observed after 30 min recovery.
For confirmation that membrane repair can occur in a single
animal, wild-type animals were pulsed with E. coli-expressed
Cry5B, immediately stained with propidium iodide, and then
recovered. After 6 hr to allow repair of pores, the same worms
were fed SYTOX Green, a dye that behaves identical to PI in
this assay except that it fluoresces at a different wavelength.
We found animals that showed PI localized to the cytosol, but
SYTOX Green localized to the lumen (Figure S5D), indicating
that membrane repair can occur within a single animal.
We next examined the requirement for RAB-5 and RAB-11 for
pore elimination after a Cry5B pulse. While no differences are
seen after 0.5 hr recovery, animals grown and recovered on
diluted rab-5 or rab-11.1 RNAi bacteria show a significantly
impaired restoration of membrane integrity compared to152 Cell Host & Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc.controls after 24 hr (Figure 5C and Table
S1). pgp-1 RNAi did not cause statisti-
cally different fractions of animals dis-
playing cytosolic PI at 0.5 or 24 hr
recovery (Figure 5C and Table S1). These
data indicate that RAB-5- and RAB-11-
controlled vesicle-trafficking pathways
are required for effective membrane
repair after an attack by PFT. In addition,
they further confirm that PI enters cells via
pores, since RAB-5 or RAB-11 knock-down would be predicted to decrease rather than increase PI
uptake by the cells if it were entering via endocytosis.
Repair after physical damage to the plasma membrane
requires Ca2+ influx through the lesions, which was also found
to be true for repair of the large pores formed by SLO (Idone
et al., 2008b). Extracellular Ca2+ is not likely required for repair
of small pores formed by S. aureus a toxin or V. cholerae VCC,
as these are Ca2+ impermeable (Walev et al., 1993; Zitzer
et al., 1997), although intracellular Ca2+ stores may still play
a role. Based on analogy to Cry1Aa and Cry1Ac, Cry5B pores
may however be permeable to Ca2+ (Kirouac et al., 2002). To
determine whether Ca2+ was required for defense against
Cry5B, we exposed wild-type animals to purified Cry5B in liquid
mediawith or without Ca2+ and quantified survival.We found that
absence of Ca2+ from the media did not significantly alter Cry5B
sensitivity (Figure S5E).
RAB-11 Is Linked to PFT-Induced Expulsion of Plasma
Membrane into the Intestinal Lumen
To ascertain directly the consequences of PFT attack on the
intestinal cells, we fixed, sectioned, and examined by transmis-
sion electron microscopy (EM) C. elegans animals treated with
Cry5B PFT for 3 hr. As a negative control, we fed Cry5B PFT to
bre-5(ye17) mutant animals, which lack the receptor required
Figure 6. Cry5B PFT Induces Expulsion of
PlasmaMembrane into the Intestinal Lumen
(A) EM images showing extensive damage to the
microvilli of the intestinal cells after 3 hr E. coli-
expressed Cry5B treatment. Unintoxicated
controls [receptor-negative bre-5(ye17) mutant]
have healthy microvilli (left). Intoxicated wild-type
animals (middle and right) show microvilli defi-
ciency (middle, arrow), and dislodged microvilli in
intestinal lumen (right, arrows). Each panel shows
a single focal plane from a different animal. All
focal planes were analyzed to confirm the lack of
microvilli or disconnection of membranous mate-
rial. Scale bars represent 0.5 mM.
(B) Deconvolved images showing PGP-1::GFP-
positive material in the intestinal lumen (arrows)
after 2 hr exposure to E. coli-expressed Cry5B.
The scale bar represents 10 mm.
(C) Confocal images showing debris in the lumen
after 5 min exposure to E. coli-expressed Cry5B.
The scale bar represents 10 mm.
(D) Fluorescence image showing PGP-1::GFP-
labeled material in the posterior bulb of the
pharynx (indicated by arrow) after exposure to
E. coli-expressed Cry5B. The scale bar represents
10 mm.
(E) Fractions of animals containing luminal PGP-
1::GFP-positive material after E. coli-expressed
Cry5B PFT treatment. Error bars represent the
standard error of the mean.
See also Figure S6 and Tables S1 and S2.
Cell Host & Microbe
RAB-5 and RAB-11 in Removal of Pore-Forming Toxinfor pore formation by Cry5B and hence are unaffected by the
toxin (Griffitts et al., 2003). Dramatic changes at the cell surface
are evident in Cry5B-intoxicated intestinal cells, which show
gaps in the regular arrangement of microvilli and a concomitant
increase in membranes present in the lumen of the intestine rela-
tive to the unaffected bre-5(ye17) control animals (Figure 6A).
These data strongly suggest that one response of the animals
to PFT attack is to dislodge or expel microvilli from the cell
surface, probably as a way to rapidly remove pores from the
cell surface. To confirm that the bre-5 mutation did not alter
our findings, we performed a similar EM experiment in which
we used wild-type animals fed empty-vector bacteria as a nega-
tive control instead. The results were consistent, as empty-
vector control-treated wild-type animals looked comparable to
bre-5(ye17) (nonintoxicated) animals treated with Cry5B, and
wild-type animals treated with Cry5B looked similar in both
experiments (Figure S6).
To determine whether microvilli expulsion is detectable in live
animals, we exposed PGP-1::GFP-expressing animals to Cry5B
PFT. We found an accumulation of detached, GFP-positive
material in the lumen of the intestine of PFT-exposed animals
(Figure 6B), consistent with our EM results that apical membrane
is being dislodged into the intestinal lumen. Like the endocytosis
phenotype, this is most obvious after 2 hr exposure to E. coli-
expressed Cry5B (Figure 6B) but already visible after 5 min (Fig-
ure 6C). The membranous material appears to be detached from
the intestinal cells, as it is sometimes encountered in the pharynx
(Figure 6D), where pgp-1::gfp is not expressed (Figure 1A), prob-Cell Hostably resulting from backward movement of luminal contents
from the intestine into the pharynx.
Since the expulsion or dislodging of plasma membrane
into the lumen would necessitate a replenishment of plasma
membrane at the cell surface via fusion of exocytic vesicles,
we hypothesized that perturbation of vesicle-trafficking path-
ways would perturb this ejection. We performed RNAi of rab-5
or rab-11.1 on PGP-1::GFP animals and then exposed them to
E. coli-expressed Cry5B as above, after which we examined
the presence of unattached PGP-1::GFP in the intestinal lumen.
We found that RNAi of rab-11.1, but not rab-5, leads to a statisti-
cally significant decrease in animals displaying PGP-1::GFP-
positive membrane structures in the intestinal lumen (Figure 6E
and Table S1). The lack of phenotype after rab-5 RNAi in this
assay might be explained by lack of penetrance with diluted
RNAi for this particular phenomenon. Thus, the expulsion or dis-
lodging of material into the lumen of the intestine requires RAB-
11, probably via fusion of vesicles with the plasma membrane.
DISCUSSION
The data presented here directly correlate vesicle trafficking,
plasma membrane repair, and survival after attack by a small-
pore bacterial PFT in an intact tissue in vivo. We show that (1)
PFT intoxication triggers an increase in endocytosis in vivo, (2)
loss of either of two key RAB proteins, RAB-5 and RAB-11,
master regulators of early and recycling endosome functions,
results in strong hypersensitivity to PFT and loss of cellular& Microbe 9, 147–157, February 17, 2011 ª2011 Elsevier Inc. 153
Figure 7. Model for PFT Pore Removal by RAB-5- and RAB-11-
Dependent Endo- and Exocytosis
Microvilli containing PFT pores (red) are expelled from the apical cell surface
through RAB-11-dependent vertex fusion (indicated with ‘‘V’’) or some other
mechanism. RAB-5-dependent endocytosis supports this process by main-
taining membrane homeostasis through increased endocytosis (indicated by
green arrow). Alternatively or in addition, pores are taken up from the plasma
membrane into the cells by RAB-5-controlled endocytosis, and potentially
transported to lysosomes. RAB-11-controlled exocytosis may balance
increased endocytosis (indicated by green arrow).
Cell Host & Microbe
RAB-5 and RAB-11 in Removal of Pore-Forming Toxinprotection against PFT, (3) loss of RAB-5 and RAB-11 results in
significant decreases in PFT-induced endocytosis, showing a
correlation between RAB-5, RAB-11, PFT-induced endocytosis
of the plasma membrane, and cellular protection, (4) RAB-5
and RAB-11 are required for normal recovery of plasma
membrane integrity (membrane resealing) in vivo after PFT
attack, and (5) RAB-11 is required for PFT-induced expulsion
of microvilli.
Taken together, these data demonstrate that an attack on the
plasma membrane by small-pore PFTs leads to a rapid (within
5 min) and dramatic increase in plasma membrane dynamics—
i.e., an increase in endocytosis and expulsion of microvilli—
that relies on both endocytic (RAB-5) and exocytic (RAB-11)
machinery and that functions to remove pores from the plasma
membrane. Although we have not directly shown the presence
of PFT on internalized or externalized membranes, we do
demonstrate the removal of pores from the plasma membrane
via PI permeability. Presence of PFTs on endosomes and exter-
nalized membranes has been seen or inferred in two studies in
mammalian cells (Husmann et al., 2009; Idone et al., 2008b).
Our data appear to be consistent with a molecular-physical
model that can explain how cells use vesicular trafficking path-
ways to repair membrane damage, the vertex fusion model
(McNeil and Kirchhausen, 2005). Here, a large vesicle forms
a patch by docking at the damaged section of plasmamembrane
via docking sites along the circumference of the patch, the vertex
ring. Fusion between the two membranes then occurs along this
vertex ring, excising a piece of damaged plasma membrane and
releasing it (Wang et al., 2002). (This is opposed to fusion via the
expanding pore model, in which all boundary membrane is con-
verted to outside membrane [Wang et al., 2002].) In the case of
membrane damaged by PFT, we hypothesize RAB-11’s role is
to control assembly and localization of the patch and/or to
directly initiate vertex fusion and that the dislodged microvilli
represent the excised membrane, in this case released extracel-
lularly (Figure 7). The role of RAB-5 in this model would be to use
endocytosis to maintain homeostasis of the plasma membrane
(Figure 7), as well as to contribute to pore removal via internaliza-
tion (see below). The vertex fusion model for membrane repair
was, however, proposed in the context of Ca2+-dependent repair
(McNeil and Kirchhausen, 2005), whereas we did not observe
a requirement for Ca2+ (Figure S5E).
Alternatively, PFT pores in the apical plasma membrane could
be quickly detected and taken up into the cells by RAB-5-
controlled endocytosis. Pores are then potentially transported
to the lysosomes for destruction. Simultaneous RAB-11-depen-
dent exocytic events provide the new plasma membrane
required to counterbalance the increased rates of endocytosis.
These exocytosed vesicles could be derived from recycling en-
dosomes or the trans-Golgi network (with which Rab11 is known
to interact [Grant and Hirsh, 1999; Grant and Donaldson, 2009]),
or lysosomes (which are known to fuse with the plasma
membrane in response to membrane damage [Idone et al.,
2008a]). Simultaneously, microvilli are expelled from the cell
surface in a RAB-11-dependent fashion, via vertex fusion (see
above), or through some other mechanism (Figure 7), thus also
playing a significant role in the removal of pore-contaminated
membrane. In this way, RAB-5-mediated endocytosis and
RAB-11-mediated exocytosis together play a role in removing154 Cell Host & Microbe 9, 147–157, February 17, 2011 ª2011 Elsevpores from the membrane, while also balancing each other out
to maintain plasma membrane homeostasis. The roles for
RAB-5 and RAB-11 in PFT defense could be analogous to their
functions during cytokinesis to reshape the plasma membrane
(Fu¨rthauer and Gonza´lez-Gaita´n, 2009). In addition to removing
pores, the dislodged microvilli might function to serve as decoys
for unbound PFT, and to dramatically reduce the cell’s surface
area so that the amount of pores relative to cell volume drops
considerably and so that fewer PFTs insert de novo.
This study is consistent with previous studies in mammalian
cells and closes important gaps in our understanding of cellular
defenses against PFTs. Consistent with our findings, others have
demonstrated that both large- and small-pore PFTs trigger
endocytic (Husmann et al., 2009; Idone et al., 2008b; Tam
et al., 2010; Thiery et al., 2010) and exocytic (Husmann et al.,
2009; Shaik et al., 2009; Tam et al., 2010) responses to PFTs in
mammalian cells. Loss of microvilli has also been observed
before in mammalian cells in response to small-pore and large-
pore PFTs, such as the thermostable direct hemolysin produced
by Vibrio parahaemolyticus (Sakurai et al., 1976) and streptolysin
O (SLO) produced by Streptococcus pyogenes (Engel et al.,
1995). SLO also triggered shedding of microparticles from cells
in vitro (Babiychuk et al., 2009), and perforin was found to induce
membrane blebbing (Keefe et al., 2005). What is demonstrated
here is a direct correlation between these events and survival
after PFT attack and the central role played in this process by
conserved RAB-5 (endocytic) and RAB-11 (exocytic) vesicle-
trafficking pathways. The striking parallel between our results
and those in mammalian cells indicate that what we characterize
here probably has significant relevance to cellular responses of
mammalian cells to PFTs. The C. elegans system therefore
provides an important genetically tractable, in vivo model for
future studies that detail vesicle trafficking and other funda-
mental cell biological process important for survival after the
most common mode of bacterial toxin attack.ier Inc.
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RAB-5 and RAB-11 in Removal of Pore-Forming ToxinSome of the most problematic multi-drug-resistant bacteria,
e.g., MRSA (methicillin-resistant S. aureus), E. faecalis, and
S.pneumoniae (WoodfordandLivermore, 2009), usePFTsascrit-
ical virulence factors. Elucidation of host cell immunity toward
PFTs can lead to the development of drugs that fortify cellular
defenses against PFTs by promoting protective molecular-phys-
ical pathways or by mimicking the way cells disarm PFTs, e.g.,
by introducing decoy membranes. Such therapeutics would
neutralize a broad and important class of virulence factors and
hence couldprovide continuedprotectionagainstmanyproblem-
atical bacterial infections. In summary,wedemonstrate that RAB-
5 and RAB-11 direct vesicle-trafficking pathways that remove
PFTs from the plasma membrane and provide cellular protection
against the single largest class of bacterial protein toxins.
EXPERIMENTAL PROCEDURES
Strains, Culture Conditions, and PFT Use
Worm strains used are outlined in Table S2 and were maintained as described
(Brenner, 1974). Bacterial strains and culture conditions are detailed in the
Supplemental Experimental Procedures. E. coli-expressed Cry5B was used
for Figures 1B, 1C, 2A, 3A, 4A, 4B, 5C, and 6A–6E and Figures S1A, S4C,
S4D S5C, S5D, and S6. Purified Cry5B (prepared as described [Cappello
et al., 2006], but with omission of the sucrose gradient) was used for Figures
2C, 2D, 3B, and 5B and Figures S2A, S5A, S5B, and S5E. Cry21A and VCC
were always administered expressed from E. coli or V. cholerae.
Microscopy and Image Editing
See the Supplemental Experimental Procedures.
Endocytosis Assays
Exposure of L4 stage PGP-1::GFP, OPT-2::GFP and PGP-1::GFP; mCher-
ry::RAB-5 animals to OP50-Cry5B, OP50-Cry21A (OP50-pQE9 empty vector
used as no-toxin control), P. aeruginosa (E. coli OP50 used as control), or
V. cholerae was done as described, except that 5-fluoro-20-deoxy-uridine
(FUdR) was omitted for P. aeruginosa (Bellier et al., 2009; Bischof et al.,
2006, 2008; Vaitkevicius et al., 2006). L4 PGP-1::GFP animals were exposed
in 48-well plates to M9 with 10 mM CuSO4, 400 mM NaCl, or water control.
Heat shock (35C) was delivered on NGM plates without bacteria. Animals
were scored as showing an endocytic response when the GFP marker was
robustly found on more than ten intracellular vesicles in the anterior half of
the intestine. Signals in the ultraviolet channel were used to distinguish
between GFP-positive vesicles and autofluorescent gut granules (Clokey
and Jacobson, 1986). At least three independent repeats were performed
for each experiment with at least 30 animals per treatment.
For determination of endocytosis after RNAi treatment, PGP-1::GFP animals
were synchronized to the L1 stage by hypochlorite treatment and overnight
starvation inM9media at room temperature and then seeded onto RNAi plates
(see the Supplemental Experimental Procedures) and grown to the L4 stage at
20C, before being exposed to OP50-Cry5B for 2 hr at 20C. Animals were
scored as above, and at least six independent repeats were done with at least
24 animals per treatment.
TRITC-BSA staining was based on published protocols (Grant et al., 2001;
Hermann et al., 2005). TRITC-BSA was cleaned on a 10,000 MW centricon
(Millipore) before use to remove any unbound TRITC. Synchronized L4 animals
were incubated 15 min at 20C in S media (Bischof et al., 2006) with 5 mg/ml
serotonin (5-HT; Sigma) (explained below) and 80 mg/ml TRITC-BSA (Invitro-
gen) in a 96-well plate. Then, purified Cry5B to 1 or 15 mg/ml final concentra-
tion, or HEPES (pH 8.0) to 1 mM (no-toxin control) was added. After 2 hr
incubation at 20C, worms were transferred to presiliconized 1.6 ml microcen-
trifuge tubes (National Scientific Supply), washed three times, and imaged
(see Microscopy and Image Editing). Three independent experiments were
performed with 10–17 animals per treatment.
When exposed to Cry5B, C. elegans rapidly ceases feeding (Wei et al.,
2003). We found that feeding on Cry5B could be forced to continue by admin-Cell Hostistration of exogenous serotonin (5-HT), a known regulator of feeding behavior
(Horvitz et al., 1982). Hence, 5-HT was added to equalize the amount of dye
ingested by animals treated with different Cry5B doses.
Toxicity Assays
Qualitative toxicity assays after RNAi treatment were based on a published
protocol (Bischof et al., 2006). Synchronized L1 rrf-3(pk1426) animals were
grown to L4 stage on RNAi at 20C, after which they were transferred to
OP50-Cry5B plates. Worms were then incubated at 20C, and observed and
imaged after 48 hr. At least three repeats were performed for each condition
with at least 15 animals per treatment.
Cry5B survival assays with RNAi in liquid were based on a published
protocol (Chen et al., 2010). RNAi bacteria were grown overnight at 37C in
LB media with 1 mg/ml carbenicillin. dsRNA expression was induced by incu-
bating with 1mM IPTG for 1 hr at 37C while shaking. Bacteria were pelleted
and resuspended in an equal volume of S media, and rab-5 and rab-11.1
clones were then diluted 1:6 with pL4440. Synchronized L1 VP303 animals
were grown to the L4 larval stage in 48-well plates on RNAi bacteria in Smedia,
in 40 hr at 25C while gently shaking. Then, FUdR to 200 mM final (to inhibit
development of the F1 generation), and either purified Cry5B to 15 mg/ml,
HEPES (pH 8.0) to 0.5 mM (no-Cry5B control), CuSO4 to 2 mM, or ddH2O
(no-CuSO4 control) were added. This was incubated 6 days at 25
C while
gently shaking, after which worms were scored for survival. Animals were
scored as dead if no activity was observed after prodding an animal three
times with a worm picker. At least three independent assays were performed
for each treatment, with three identical wells with 20 animals per assay.
Pore Repair Assay
Synchronized L1 rrf-3(pk1426) animals were grown on RNAi at 20C. L4 stage
animals were transferred fromRNAi to an OP50-Cry5B plate and incubated for
15 min at 20C. After this Cry5B pulse, worms were transferred to fresh RNAi
plates and allowed to recover at 20C for 0.5 or 24 hr. They were then trans-
ferred to presiliconized microcentrifuge tubes with M9 with 5 mg/ml serotonin
and incubated 15 min at 20C while shaking, after which propidium iodide
(Sigma) was added to 6.7 mg/ml. This was incubated 45 min at 20C while
shaking, after which worms were washed twice with M9 media and mounted
on slides. Animals were scored positive for cytosolic PI staining if at least
one of the enterocytes in the anterior half of the animal was filled with propi-
dium iodide. At least three independent repeats were performed with 30
animals per treatment. For Figures 5A and 5B, animals were treated in wells
containing S media, HEPES (1 mM, pH 8.0) or Cry5B (33.5 mg/ml), and PI for
2 hr at 20C.
Statistical Analyses
Statistical analyses were performed with JMP 8 software (SAS Institute). Frac-
tions of the population showing endocytosis in the PGP-1::GFP assay were
compared by one-way ANOVA (CuSO4 and NaCl assay) or Student’s t test
(the remaining data sets in Table S1). Fractions of animals alive in the Cry5B
and CuSO4 liquid assays (Figures 3B and 3C and Figure S5E), and fractions
of animals showing cytosolic staining in the pore repair assays (Figure 5C)
were compared by two-way ANOVA with Tukey’s post test. Relative levels
of TRITC-BSA fluorescence or autofluorescence intensity (Figure 2D and Fig-
ure S2B) were compared with one way ANOVA with Tukey’s post test. See
Table S1 for mean values and standard error of the mean found for all exper-
iments, and confidence limits and p values calculated with JMP 8. Graphs
were prepared with GraphPad Prism 5 software (GraphPad, San Diego, CA).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at doi:10.
1016/j.chom.2011.01.005.
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